Canopy Growth (TSE:WEED – Free Report) had its price objective cut by Canaccord Genuity Group from C$2.50 to C$1.50 in a research note issued to investors on Monday,BayStreet.CA reports. They currently have a sell rating on the stock.
Separately, ATB Capital cut shares of Canopy Growth from a “sector perform” rating to an “underperform” rating and dropped their price objective for the stock from C$6.00 to C$4.00 in a research report on Tuesday, December 17th. Four equities research analysts have rated the stock with a sell rating and one has issued a hold rating to the stock. Based on data from MarketBeat.com, Canopy Growth has an average rating of “Reduce” and a consensus target price of C$5.40.
Read Our Latest Report on WEED
Canopy Growth Stock Down 1.5 %
About Canopy Growth
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.
Featured Articles
- Five stocks we like better than Canopy Growth
- What is Insider Trading? What You Can Learn from Insider Trading
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
- Manufacturing Stocks Investing
- Inflation Persists, But So Do Stock Opportunities: Rally On
- Industrial Products Stocks Investing
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.